© Motortion iStockphoto

Diffuse large B-cell lymphoma

Six-month analysis of tisagenlecleucel shows sustained responses

<p class="article-intro">Stephen J. Schuster, MD, University of Pennsylvania, presents the primary analysis of JULIET: a global pivotal phase-II-trial of CTL019 in adult patients with relapsed or refractory diffuse large B-cell lymphoma.</p> <hr /> <p class="article-content"><p><iframe src="https://player.vimeo.com/video/246954389" width="640" height="360" frameborder="0" allowfullscreen="allowfullscreen"></iframe></p></p>
Back to top